In contrast, in the controlled hypertension, OSA showed a 1.23-fold higher risk of cardiac events in the OSA group than in those without OSA, and as adjusted for confounding factors, the P value did not reach statistical significance (P=0.489).
← all excerpts
Obstructive sleep apnea remains a risk factor for major adverse cardiovascular and cerebrovascular events even in hypertensive patients under treatment: the Urumqi Research on Sleep Apnea and Hypertension (UROSAH) data.
1
0.4890
0.4890